BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31032899)

  • 1. Translational repression of Ccl5 and Cxcl10 by 4E-BP1 and 4E-BP2 restrains the ability of mouse macrophages to induce migration of activated T cells.
    William M; Leroux LP; Chaparro V; Graber TE; Alain T; Jaramillo M
    Eur J Immunol; 2019 Aug; 49(8):1200-1212. PubMed ID: 31032899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF4E-Binding Proteins 1 and 2 Limit Macrophage Anti-Inflammatory Responses through Translational Repression of IL-10 and Cyclooxygenase-2.
    William M; Leroux LP; Chaparro V; Lorent J; Graber TE; M'Boutchou MN; Charpentier T; Fabié A; Dozois CM; Stäger S; van Kempen LC; Alain T; Larsson O; Jaramillo M
    J Immunol; 2018 Jun; 200(12):4102-4116. PubMed ID: 29712774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes enhances translation of
    Dierschke SK; Toro AL; Miller WP; Sunilkumar S; Dennis MD
    J Biol Chem; 2020 Jul; 295(31):10831-10841. PubMed ID: 32475820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4E-BP1 and 4E-BP2 double knockout mice are protected from aging-associated sarcopenia.
    Le Bacquer O; Combe K; Patrac V; Ingram B; Combaret L; Dardevet D; Montaurier C; Salles J; Giraudet C; Guillet C; Sonenberg N; Boirie Y; Walrand S
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):696-709. PubMed ID: 30927336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
    Aguilar-Valles A; De Gregorio D; Matta-Camacho E; Eslamizade MJ; Khlaifia A; Skaleka A; Lopez-Canul M; Torres-Berrio A; Bermudez S; Rurak GM; Simard S; Salmaso N; Gobbi G; Lacaille JC; Sonenberg N
    Nature; 2021 Feb; 590(7845):315-319. PubMed ID: 33328636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1.
    Böhm R; Imseng S; Jakob RP; Hall MN; Maier T; Hiller S
    Mol Cell; 2021 Jun; 81(11):2403-2416.e5. PubMed ID: 33852892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.
    Kaur S; Lal L; Sassano A; Majchrzak-Kita B; Srikanth M; Baker DP; Petroulakis E; Hay N; Sonenberg N; Fish EN; Platanias LC
    J Biol Chem; 2007 Jan; 282(3):1757-68. PubMed ID: 17114181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1.
    Murooka TT; Rahbar R; Platanias LC; Fish EN
    Blood; 2008 May; 111(10):4892-901. PubMed ID: 18337562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of genes encoding eIF4E binding proteins-1 and -2 does not alter basal or sepsis-induced changes in skeletal muscle protein synthesis in male or female mice.
    Steiner JL; Pruznak AM; Deiter G; Navaratnarajah M; Kutzler L; Kimball SR; Lang CH
    PLoS One; 2014; 9(6):e99582. PubMed ID: 24945486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic target of rapamycin complex 1 (mTORC1)-mediated phosphorylation is governed by competition between substrates for interaction with raptor.
    Dennis MD; Kimball SR; Jefferson LS
    J Biol Chem; 2013 Jan; 288(1):10-9. PubMed ID: 23184952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage inflammatory protein-1alpha and interferon-inducible protein 10 inhibit synergistically induced growth factor stimulation of MAP kinase activity and suppress phosphorylation of eukaryotic initiation factor 4E and 4E binding protein 1.
    Aronica SM; Gingras AC; Sonenberg N; Cooper S; Hague N; Broxmeyer HE
    Blood; 1997 May; 89(10):3582-95. PubMed ID: 9160663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
    Ding M; Van der Kwast TH; Vellanki RN; Foltz WD; McKee TD; Sonenberg N; Pandolfi PP; Koritzinsky M; Wouters BG
    Mol Cancer Res; 2018 Apr; 16(4):682-695. PubMed ID: 29453322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique.
    Batool A; Aashaq S; Andrabi KI
    Eur J Cell Biol; 2017 Jun; 96(4):325-336. PubMed ID: 28427795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting 4E-BP1 re-activation represses podocyte cell cycle re-entry and apoptosis induced by adriamycin.
    Li F; Mao X; Zhuang Q; Zhao Z; Zhang Z; Wu H
    Cell Death Dis; 2019 Mar; 10(3):241. PubMed ID: 30858353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
    Jossé L; Xie J; Proud CG; Smales CM
    Biochem J; 2016 Dec; 473(24):4651-4664. PubMed ID: 27760840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2.
    Grolleau A; Wietzerbin J; Beretta L
    Leukemia; 2000 Nov; 14(11):1909-14. PubMed ID: 11069026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4E-BP2-dependent translation in parvalbumin neurons controls epileptic seizure threshold.
    Sharma V; Sood R; Lou D; Hung TY; Lévesque M; Han Y; Levett JY; Wang P; Murthy S; Tansley S; Wang S; Siddiqui N; Tahmasebi S; Rosenblum K; Avoli M; Lacaille JC; Sonenberg N; Khoutorsky A
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic Initiation Factor 4E (eIF4E) sequestration mediates 4E-BP1 response to rapamycin.
    Batool A; Majeed ST; Aashaq S; Majeed R; Shah G; Nazir N; Andrabi KI
    Int J Biol Macromol; 2019 Mar; 125():651-659. PubMed ID: 30552925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis.
    Dennis MD; Jefferson LS; Kimball SR
    J Biol Chem; 2012 Dec; 287(51):42890-9. PubMed ID: 23105104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.